IQVIA · 5 hours ago
Clinical Research Coordinator, On-Site, Kansas City, MO
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. The Clinical Research Coordinator will manage multiple trials, perform clinical procedures, and coordinate study activities while collaborating with investigators, sponsors, and monitors.
AnalyticsHealth CareLife Science
Responsibilities
Manage 2–6 trials of varying complexity, perform clinical procedures, and lead study coordination from start to finish
Work closely with investigators, sponsors, and monitors while mentoring junior staff and contributing to internal training
Qualification
Required
Hands-on experience in obtaining vital signs, performing phlebotomy, conducting ECGs, and processing lab specimens
Solid understanding of site operations and the drug development process
Minimum of 1-3 years in clinical research setting at a clinical investigative site working with participants for CRC I
Minimum of 3 years as a Clinical Research Coordinator in a clinical investigative site working with participants for CRC II
Strong written and verbal communication skills, with attention to detail and time management
Comfortable using CTMS, eCRFs, and Microsoft Office tools
Benefits
Incentive plans
Bonuses
Health and welfare and/or other benefits
Company
IQVIA
IQVIA provides analytics, compliance, and management solutions to the life sciences industry.
H1B Sponsorship
IQVIA has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (134)
2024 (299)
2023 (263)
2022 (229)
2021 (208)
2020 (180)
Funding
Current Stage
Public CompanyTotal Funding
$3.5B2025-06-02Post Ipo Debt· $2B
2023-11-14Post Ipo Debt· $500M
2023-05-18Post Ipo Debt· $1B
Leadership Team
Recent News
Sabin Vaccine Institute
2025-12-04
Company data provided by crunchbase